BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22825850)

  • 1. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
    Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
    J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.
    Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH
    EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation.
    Peuget S; Bonacci T; Soubeyran P; Iovanna J; Dusetti NJ
    Cell Death Differ; 2014 Jul; 21(7):1107-18. PubMed ID: 24608790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
    Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
    Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA end resection requires constitutive sumoylation of CtIP by CBX4.
    Soria-Bretones I; Cepeda-García C; Checa-Rodriguez C; Heyer V; Reina-San-Martin B; Soutoglou E; Huertas P
    Nat Commun; 2017 Jul; 8(1):113. PubMed ID: 28740167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
    Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
    Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage.
    Ismail IH; Gagné JP; Caron MC; McDonald D; Xu Z; Masson JY; Poirier GG; Hendzel MJ
    Nucleic Acids Res; 2012 Jul; 40(12):5497-510. PubMed ID: 22402492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
    Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
    PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
    Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
    Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
    Jiang M; Chiu SY; Hsu W
    Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine methylation of hnRNP K enhances p53 transcriptional activity.
    Chen Y; Zhou X; Liu N; Wang C; Zhang L; Mo W; Hu G
    FEBS Lett; 2008 May; 582(12):1761-5. PubMed ID: 18472002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
    Weger S; Hammer E; Heilbronn R
    FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA activates the Nse2/Mms21 SUMO E3 ligase in the Smc5/6 complex.
    Varejão N; Ibars E; Lascorz J; Colomina N; Torres-Rosell J; Reverter D
    EMBO J; 2018 Jun; 37(12):. PubMed ID: 29769404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.